Albert David Profile, SWOT Analysis and Company Tech Intelligence Report 2018

Report Name: ALBERT DAVID Profile – Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

ALBERT DAVID Report – Publisher: Research Cosmos

Price Scheme of the Report:

Single User License – USD 150

Team License – USD 175

Corporate License – USD 250

ALBERT DAVID – Business Description:

Albert David Ltd is an India-based pharmaceutical company that manufactures and distributes pharmaceutical formulations, bulk drugs, infusion solutions, oral solids and herbal formulations. It is a part of G D Kothari Group of Companies. It operates in Bhopal, Lucknow, Vijayawada, Delhi, Chennai, Guwahati, Patna, Mumbai and Kolkata. The company offers its products in the following therapeutic segments: analgesics anti-inflammatory; anti-bacterials; anti-ulcerants; dermatologicals; anxiolytics; large volume parenterals; disposable syringes and needles; herbal drugs; nutrition; neurotropics; anthelmintic; haemostatic; cough preparations; laxatives; skeletal relaxants; anti-arthiritic and chondroprotective agents. Albert David offers analgesics that are the drugs that relieve pain, anti-inflammatory drugs arrest the process of inflammation, and anti-pyretics relieve fever. Anti-bacterials and anti-protozoals include antibiotics such as penicillin aminoglycosides and macrolides; sulphonamides quinolones and nitro imidazoles; and metronidazoles, which is used in anaerobic infections. The company offers anti-ulcerants used to treat and prevent peptic ulcer disease and other disorders associated with gastric hyperacidity. These drugs are either antisecretary, which reduce the gastric acid secretion or cytoprotective having gastric mucosal protectant actions. Its key products include ranial tablet, siozole capsule and pansure tablet. Albert David’s herbal drugs comprised of siotone capsules, adliv forte capsules, adliv syrup and adliv drops. The products offered by the nutrition and vitamins segment include alamin forte capsule, sioplex lysine, sioneuron injection, sioneuron tablet, leclyte W, alamin M capsule, sioneuron forte tablets and alamin injection in 20 milliliter (ml) ampoule. The company’s haematinics products maintain blood in fluid state within the vasculature and minimize blood loss. Its key products include alstat tablet and alstat injection. The company’s cough preparations include siokof tablets and siokof syrup for relief from cough. Anthelmintic segment offers drugs to treat helminthis or worm infestations that occur in human beings. Its products include sioban tablet and sioban suspension. Albert David’s laxatives include osmotic laxative it is a colonic acidifier. Its key product include evict. Albert David’s skeletal relaxants include nimeral-T tablets. Anti-arthiritic and chondroprotective agents enhance the chondrocyte macro molecular synthesis such as glycosaminoglycans, proteoglycans, collagen, protein DNA (deoxyribonucleic acid), RNA (ribonucleic acid), enhances synthesis by cartilage matrix, reduces joint pains and reduces synovitis. The company offers its products in the following four categories: Formulations, Bulk Drugs, Disposable Syringes and Disposable needles. These products are available in capsules, injections, tablets and syrup. Albert David offers formulations products through parenterals, oral/enteral, topical agents and vision care. The company’s parenterals offers amino acids, anti-microbial, anti-leishmanias (kalazar), haemostat (Inj), large volume parenterals (LVP), neurotropic vitamin, placentrex (Inj) and tocolytic (inj). Albert David’s oral/enteral product offers amino acids oral, anthelmintic, anti-microbial, anti ulcerants, anti-vertigo, antispasmodics, appetite stimulants, expectorant/cough syrup, haematinics, haemostat, hepato protective (ayurveda), hepato protective (others), laxative, neurotropic vitamin, NSAID, omega 3, oral vitamin B complex, rejuvenator/anti stress, short acting SSRI, systemic alkaliser, tocolytic, uricosuric and uterotonics. The company’s topical agent’s product comprises NSAID, placentae therapy and topical antibacterial. Albert David’s vision care product includes vision care range anti-infective, anti-inflammatory, tear substitutes and anti-glaucoma. The company offers bulk drugs products through chlorpropamide (USP), tolbutamide (USP) and iodoquinol. Albert David also offers disposable syringes and needles.

Scope of the Report:

About the Company: Historical Details, Current Ownership Structure and basic overview of Balfour Beatty plcin terms of revenue, net income, and operating income.

Financials: Details about Balfour Beatty plclisting status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

Products/Services: Listing of the company’s entire portfolio along with the description of individual products/services providing a clear picture of their target audience.

Company SWOT Analysis: Outlines Atea ASA.’s strengths, weaknesses, and opportunities and threats facing the company.

Recent Developments: Showcases Atea ASA.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

Strategic Evaluation: This section provides an overview of Atea ASA.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

Technology Landscape: Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken by the company at present along with outlook.

Key Questions Answered

What domain does Balfour Beatty plcoperate and what are key points about it?

What is the product/service portfolio of Atea ASA.?

How has Balfour Beatty plcperformed financially from 2013?

How does Balfour Beatty plcrank among its peers in terms of revenue and market share?

What are Balfour Beatty plcstrengths and weaknesses and what opportunities and threats do it face?

What are Atea ASA.’s main growth strategies and how successful has the company been at implementing them?

What is the in-house technical capability of Atea ASA.? Where does it procure/outsource it?

Reasons to buy

Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at a very competitive cost

12 hour delivery time fulfilling your urgent requests as per your requirement

On-demand customization options that can completely cater to your needs by focusing the report on given specifics

For More Information, Get Sample of the report:Request Sample

Got Some Questions? Inquire Here:Inquire Before Buying

Get This Report:Purchase Now

For More Details, Contact Provider Directly:

Kevin Stewart
Sales Manager
Research Cosmos
+1 888 709 8757

Be the first to comment

Leave a Reply